OCTAGON CAPITAL ADVISORS LP – Arcus Biosciences, Inc. Transaction History
OCTAGON CAPITAL ADVISORS LP portfolio value:
$69.80M
portfolio value
OCTAGON CAPITAL ADVISORS LP quarter portfolio value change:
+3.24%
quarter
Arcus Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.06% | -1.65K shares | 2.14M | $26.16 | 2.66M |
| Q2 2022 | share | Increase | +7.23% | 180K shares | -10.92M | $25.34 | 2.66M |
| Q1 2022 | share | Increase | +18.84% | 394.74K shares | -6.21M | $31.56 | 2.48M |
| Q4 2021 | share | Increase | +115.97% | 1.12M shares | 50.96M | $41.95 | 2.09M |
| Q3 2021 | share | Increase | +27.63% | 210K shares | 12.95M | $34.87 | 970.16K |
| Q2 2021 | share | Increase | +90.04% | 360.16K shares | 9.64M | $27.46 | 760.16K |
| Q1 2021 | share | Increase | +33.33% | 100K shares | 3.44M | $28.08 | 400K |
| Q4 2020 | share | Increase | 0.00% | 300K shares | 7.78M | $25.96 | 300K |